Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone for Threatened Miscarriage
NCT02690129Unknown
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in threatened miscarriage (2 arms). Primary endpoint: Miscarriage rate up to 28 weeks of gestation. Status: unknown.
02
Drugs
progesterone
03
Conditions
threatened miscarriage
Beyond the preview
Go deeper on NCT02690129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02690129.